Not Signed In - New Analysis in Patients with Type 2 Diabetes from Trial with VYTORIN™ (ezetimibe/simvastatin) Presented at ADA
Wed, 20 Jul 2005 03:00 AM EST
... Consistent with Overall Study which Showed Superior LDL Cholesterol Reduction with VYTORIN versus Lipitor - SAN DIEGO, June 13, 2005 - Results from a new prespecified analysis of the VYVA (VYtorin Versus Atorvastatin) trial involving a subgroup of 428 patients with type 2 diabetes were consistent with the overall VYVA trial announced earlier this year... click link for more info. ...
Related Topics
- Diabetes - Type 1
- Diabetes - Type 2
- Clinical Trials
- Ezetimibe
- Juvenile Diabetes
- Data Analysis
- Simvastatin
- Diabetes and Pregnancy
- Diabetes Insipidus
- Gestational Diabetes
- Diabetic Diet
- Diabetes
- Type 2 diabetes
- Type 1 diabetes
- Diabetes Type 1
- Mucopolysaccharidosis
- Seizures (in about half of patients)
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Smoking Cessation and Continued Risk in Cancer Patients
email this page
print this page
bookmark this page
feedback on this page
